Antiendothelial cell antibodies in vasculitis and connective tissue disease

Annals of the Rheumatic Diseases

Volumn 65, Issue 12, 2006, Pages 1545-1550

  Belizna, C ^a   Duijvestijn, A ^b   Hamidou, M ^c   Tervaert, J W Cohen ^b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; ENDOTHELIAL CELL ANTIBODY; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; MYELOBLASTIN; MYELOPEROXIDASE;

APOPTOSIS; BLOOD CLOTTING; BLOOD VESSEL INJURY; CONNECTIVE TISSUE DISEASE; CYTOTOXICITY; DISEASE ACTIVITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNIZATION; LEUKOCYTE ADHERENCE; MOLECULAR CLONING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VASCULITIS;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BLOOD COAGULATION; CONNECTIVE TISSUE DISEASES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; VASCULITIS;

EID: 33750340288     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.035295     Document Type: Review

References (81)

1. Schoen FJ. Blood vessels. In: Cotran RS, Kumar V, Robbins SL, eds. Robbins pathologic basis of disease. 6th edn. Philadelphia: Saunders, 2000:467-516.
2. Renaudineau Y, Grunebaum E, Krause I, Praprotnik S, Revelen R, Youinou P. Anti-endothelial cell antibodies (AECA) in systemic sclerosis-increased sensitivity using different endothelial cell substrates and association with other autoantibodies. Autoimmunity 2001;33:171-9.
3. Belizna C, Cohen-Tervaert JW. Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies. Semin Arthritis Rheum 1997;27:98-109.
4. Bordron A, Revelen R, D'Arbonneau F, Dueymes M, Renaudineau Y, Jamin C, et al. Functional heterogeneity of anti-endothelial cell antibodies. Clin Exp Immunol 2001;124:492-501.
5. Linquist KJ, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol 1971;9:753-60.
6. Cines DB, Lyss AP, Reeber M, Bina M, DeHoratius RJ. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest 1984;73:611-25.
7. Rosenbaum J, Pottinger BE, Woo P, Black CM, Loizou S, Byron MA, et al. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988;72:450-6.
8. Matsuda J, Gotoh M, Gohchi K, Kawasugi K, Tsukamoto M, Saitoh N. Anti-endothelial cell antibodies to the endothelial hybridoma cell line (EAhy926) in systemic lupus erythematosus patients with antiphospholipid antibodies. Br J Haematol 1997;97:227-32.
9. van Leeuwen EB, Wisman GB, Tervaert JW, Palmans LL, van Wijk RT, Veenstra R, et al. An SV40 large T-antigen immortalized human umbilical vein endothelial cell line for anti-endothelial cell antibody detection. Clin Exp Rheumatol 2001;19:283-90.
10. Revelen R, D'Arbonneau F, Guillevin L, Bordron A, Youinou P, Dueymes M. Comparison of cell-ELISA, flow cytometry and Western blotting for the detection of antiendothelial cell antibodies. Clin Exp Rheumatol 2002;20:19-26.
11. Revelen R, Bordron A, Dueymes M, Youinou P, Arvieux J. False positivity in a cyto-ELISA for anti-endothelial cell antibodies caused by heterophile antibodies to bovine serum proteins. Clin Chem 2000;46:273-8.
12. Del Papa N, Guidali L, Sironi M, Shoenfeld Y, Mantovani A, Tincani A, et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996;39:758-66.
13. Tripathy NK, Upadhyaya S, Sinha N, Nityanand S. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis. J Rheumatol 2001;28:805-8.
14. Leung DY, Collins T, Lapierre LA, Geha RS, Pober JS. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986;77:1428-35.
15. Del Papa ND, Raschi E, Moroni G, Panzeri P, Borghi MO, Ponticelli C, et al. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a proinflammatory phenotype in vitro. Lupus 1999;8:423-9.
16. Yazici ZA, Raschi E, Patel A, Testoni C, Borghi MO, Graham AM, et al. Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro. Int Immunol 2001;13:349-57.
17. Carvalho D, Savage CO, Isenberg D, Pearson JD. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 1999;42:631-40.
18. Lee KH, Cho HJ, Kim HS, Lee WJ, Lee S, Bang D. Activation of extracellular signal regulated kinase 1/2 in human dermal microvascular endothelial cells stimulated by anti-endothelial cell antibodies in sera of patients with Behcet's disease. J Dermatol Sci 2002;30:63-72.
19. Min W, Pober JS. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-jun/ ATF2 pathways. J Immunol 1997;159:3508-18.
20. Read MA, Whitley MZ, Gupta S, Pierce JW, Best J, Davis RJ, et al. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor kappa B and the c-JUN N-terminal kinase/p38 mitogen activated protein kinase pathways. J Biol Chem 1997;272:2753-61.
21. Meroni PL, Raschi E, Testoni C, Tincani A, Balestrieri G, Molteni R, et al. Statins prevent endothelial cell activation induced by antiphospholipid antibeta2-glycoprotein I antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 2001;44:2870-8.
22. Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986;137:1532-7.
23. Kornberg A, Renaudineau Y, Blank M, Youinou P, Shoenfeld Y. Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells. Isr Med Assoc J 2000;2(Suppl):27-31.
24. de Groot PG, Horbach DA, Derksen RH. Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis. Lupus 1996;5:488-93.
25. Tomas JF, Alberca I, Tabernero MD, Cordero M, Del Pino-Montes J, Vicente V. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1998;25:57-62.
26. Merrill JT, Zhang HW, Shen C, Butman BT, Jeffries EP, Lahita RG, et al. Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. Thromb Haemost 1999;81:748-57.
27. Ishikawa H, Saito Y, Ymakage A, Kitabatake M. Scleroderma-inducing glycosaminoglycan in the urine of patients with systemic scleroderma. Dermatologica 1978;156:193-204.
28. Harper L, Savage CO. Anti-heparin antibodies: part of the repertoire of anti-endothelial cell antibodies (AECA). Lupus 1998;7:68-72.
29. Dimitriu-Bona A, Matic M, Ding W, Yang CP, Fillit H. Cytotoxicity to endothelial cells by sera from aged MRL/lpr/lpr mice is associated with autoimmunity to cell surface heparan sulfate. Clin Immunol Immunopathol 1995;76:234-40.
30. Patton WA II, Granzow CA, Getts LA, Thomas SC, Zotter LM, Gunzel KA, et al. Identification of a heparin-binding protein using monoclonal antibodies that block heparin binding to porcine aortic endothelial cells. Biochem J 1995;311:461-9.
31. Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 2000;43:2550-62.
32. Bordron A, Dueymes M, Levy Y, Jamin C, Leroy JP, Piette JC, et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998;101:2029-35.
33. Worda M, Sgonc R, Dietrich H, Niederegger H, Sundick RS, Gershwin ME, et al. In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum 2003;48:2605-14.
34. Le Tonqueze M, Dueymes M, Giovangrandi Y, Beigbeder G, Jouquan J, Pennec YL, et al. The relationship of anti-endothelial cell antibodies to antiphospholipid antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica. Autoimmunity 1995;20:59-66.
35. Dueymes M, Levy Y, Ziporen L, Jamin C, Piette JC, Shoenfeld Y, et al. Do some antiphospholipid antibodies target endothelial cells? Ann Med Interne 1996;147(Suppl 1):22-3.
36. Nakamura N, Shidara Y, Kawaguchi N, Azuma C, Mitsuda N, Onishi S, et al. Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V. Biochem Biophys Res Commun 1994;205:1488-93.
37. Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A, et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995;13:179-85.
38. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997;40:551-61.
39. Bordron A, Dueymes M, Levy Y, Jamin C, Ziporen L, Piette JC, et al. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum 1998;41:1738-47.
40. Dieude M, Senecal JL, Raymond Y. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum 2004;50:3221-31.
41. Meroni PL, Raschi E, Testoni C, Parisio A, Borghi MO. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun Rev 2004;3:510-15.
42. Meroni PL, Borghi MO, Raschi E, Ventura D, Sarzi Puttini PC, Atzeni F, et al. Inflammatory response and the endothelium. Thromb Res 2004;114:329-34.
43. Direskeneli H, D'Cruz D, Khamashta AM, Hughes RV. Autoantibodies against endothelial cells, extracellular matrix, and human collagen IV in patients with systemic vasculitis. Clin Immunol Immunopathol 1994;70:206-10.
44. Mayet WJ, Meyer zum Buschenfelde KH. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 1993;94:440-6.
45. Heeringa P, Cohen Tervaert JW. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Kidney Int 2004;65:1564-7.
46. Zhu M, Olee T, Le DT, Roubey RA, Hahn BH, Woods VL Jr, et al. Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies. Br J Haematol 1999;105:102-9.
47. Chan TM, Frampton G, Staines NA, Hobby P, Perry GJ, Cameron JS. Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells. Clin Exp Immunol 1992;88:68-74.
48. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti- endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum 2001;44:1484-94.
49. Page C, Rose M, Yacoub M, Pigott R. Antigenic heterogeneity of vascular endothelium. Am J Pathol 1992;141:673-83.
50. Zetter BR. The endothelial cells of large and small blood vessels. Diabetes 1981;30(Suppl 2):24-8.
51. Alderuccio F, Barnett AJ, Campbell JH, Pedersen JS, Toh BH. Scl-95-100: doublet of endothelial marker autoantigens in progressive systemic sclerosis. Clin Exp Immunol 1986;64:94-100.
52. van der Zee JM, Siegert CE, de Vreede TA, Daha MR, Breedveld FC. Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE). Clin Exp Immunol 1991;84:238-44.
53. Kaneko K, Savage COS, Pottinger BE, Shah V, Pearson JD, Dillon MJ. Anti-endothelial cell antibodies can be cytotoxic to endothelial cells without cytokine prestimulation and correlate with ELISA antibody measurement in Kawasaki disease. Clin Exp Immunol 1994;8:264-9.
54. Del Papa N, Conforti G, Gambini D, La Rosa L, Tincani A, D'Cruz D, et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994;70:211-16.
55. Frampton G, Moriya S, Pearson JD, Isenberg DA, Ward FJ, Smith TA, et al. Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen. Rheumatology 2000;39:1114-20.
56. van der Zee JM, Heurkens AH, van der Voort EA, Daha MR, Breedveld FC. Characterization of anti-endothelial antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Rheumatol 1991;9:589-94.
57. Renaudineau Y, Dugue C, Dueymes M, Youinou P. Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev 2002;1:365-72.
58. Matsuda M. Experimental glomerular tissue injury induced by immunization with cultured endothelial cell plasma membrane. Acta Pathol Japan 1988;38:823-39.
59. Matsuo S, Fukatsu A, Taub ML, Caldwell PR, Brentjens JR, Andres G. Glomerulonephritis induced in the rabbit by antiendothelial antibodies. J Clin Invest 1987;79:1798-811.
60. Damianovich M, Gilburd B, George J, Del Papa N, Afek A, Goldberg I, et al. Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol 1996;156:4946-51.
61. Matsumiya G, Shirakura R, Miyagawa S, Izutani H, Sawa Y, Nakata S, et al. Analysis of rejection mechanism in the rat to mouse cardiac xenotransplantation. Role and characteristics of anti-endothelial cell antibodies. Transplantation 1994;57:1653-60.
62. Fischel RJ, Matas AJ, Platt JL, Perry E, Noreen H, Shumway SJ, et al. Cardiac xenografting in the pig-to-rhesus monkey model: manipulation of antiendothelial antibody prolongs survival. J Heart Lung Transplant 1992;11:965-73.
63. Richards AC, Davies HF, McLaughlin ML, Copeman LS, Holmes BJ, Dos Santos Cruz G, et al. Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation. Transplantation 2002;73:881-9.
64. Li JS, Liu MF, Lei HY. Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erythematosus: a potential marker for disease activity. Clin Immunol Immunopathol 1996;79:211-16.
65. Song J, Park YB, Lee WK, Lee KH, Lee SK. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2000;20:1-7.
66. Boomsma MM, Stearns-Kurosawa DJ, Stegeman CA, Raschi E, Meroni PL, Kurosawa S, et al. Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis. Clin Exp Immunol 2002;128:187-94.
67. Chan TM, Frampton G, Jayne DR, Perry GJ, Lockwood CM, Cameron JS. Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies. Am J Kidney Dis 1993;22:387-92.
68. Gobel U, Eichhorn J, Kettritz R, Briedigkeit L, Sima D, Lindschau C, et al. Disease activity and autoantibodies to endothelial cells in patients with Wegener's granulomatosis. Am J Kidney Dis 1996;28:186-94.
69. Bootsma H, Spronk PE, Ter Barg EJ, Hummel EJ, de Boer G, Limburg PC, et al. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation. Ann Rheum Dis 1997;56:661-6.
70. Hill MB, Phipps JL, Milford-Ward A, Greaves M, Hughes P. Further characterization of anti-endothelial cell antibodies in systemic lupus erythematosus by controlled immunoblotting. Br J Rheumatol 1996;35:1231-8.
71. Navarro M, Cervera R, Font J, Reverter JC, Monteagudo J, Escolar G, et al. Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 1997;6:521-6.
72. Perry GJ, Elston T, Khouri NA, Chan TM, Cameron JS, Frampton G. Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage. Q J Med 1993;86:727-34.
73. Yoshio T, Masuyama J, Sumiya M, Minota S, Kano S. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1994;21:2058-63.
74. D'Cruz DP, Houssiau FA, Ramirez G, Baguley E, McCutcheon J, Vianna J, et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol 1991;85:254-61.
75. Moroni G, Trendelenburg M, Del Papa N, Quaglini S, Raschi E, Panzeri P, et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001;37:490-8.
76. Negi VS, Tripathy NK, Misra R, Nityanand S. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol 1998;25:462-6.
77. Pignone A, Scaletti C, Matucci-Cerinic M, Vazquez-Abad D, Meroni PL, Del Papa N, et al. Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. Clin Exp Rheumatol 1998;16:527-32.
78. Ihn H, Sato S, Fujimoto M, Igarashi A, Yazawa N, Kubo M, et al. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 2000;119:203-9.
79. Hebbar M, Lassalle P, Delneste Y, Hatron PY, Devulder B, Tonnel AB, et al. Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjogren's syndrome. Ann Rheum Dis 1997;56:230-4.
80. Salojin KV, Le Tonqueze M, Saraux A, Nassonov EL, Dueymes M, Piette JC, et al. Antiendothelial cell antibodies: useful markers of systemic sclerosis. Am J Med 1997;102:178-85.
81. Salih AM, Nixon NB, Dawes PT, Mattey DL. Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. J Rheumatol 1999;26:551-5.